SG Americas Securities
KNSA icon

SG Americas Securities’s Kiniksa Pharmaceuticals KNSA Stock Holding History

SG Americas Securities’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.2M Sell
504,001
-136,178
-21% -$7.06M 0.02% 462
2026
Q1 		$30.8M Buy
640,179
+98,783
+18% +$4.38M 0.03% 401
2025
Q4 		$22.3M Buy
541,396
+402,078
+289% +$16.1M 0.03% 465
2025
Q3 		$5.41M Buy
139,318
+4,914
+4% +$160K 0.02% 483
2025
Q2 		$3.72M Buy
134,404
+127,126
+1,747% +$3.24M 0.02% 551
2025
Q1 		$162K Sell
7,278
-10,692
-59% -$220K ﹤0.01% 2688
2024
Q4 		$355K Buy
+17,970
New +$410K ﹤0.01% 1643
2024
Q3 		– Sell
-69,226
Closed -$1.29M – 3516
2024
Q2 		$1.29M Buy
69,226
+50,066
+261% +$938K 0.01% 1180
2024
Q1 		$378K Buy
19,160
+1,435
+8% +$28K ﹤0.01% 1557
2023
Q4 		$311K Buy
+17,725
New +$291K ﹤0.01% 1807
2023
Q2 		– Sell
-15,619
Closed -$168K – 2738
2023
Q1 		$168K Buy
+15,619
New +$206K ﹤0.01% 2554
2021
Q4 		– Sell
-18,551
Closed -$211K – 3611
2021
Q3 		$211K Buy
+18,551
New +$242K ﹤0.01% 3201
2021
Q2 		– Sell
-5,694
Closed -$105K – 3054
2021
Q1 		$105K Buy
+5,694
New +$116K ﹤0.01% 3060
2020
Q4 		– Sell
-94,543
Closed -$1.45M – 3407
2020
Q3 		$1.45M Buy
94,543
+56,324
+147% +$1.06M 0.01% 978
2020
Q2 		$974K Buy
+38,219
New +$798K 0.01% 1442

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

SG Americas Securities's KNSA Position: Q2 2026 in Review

SG Americas Securities reduced its Kiniksa Pharmaceuticals (KNSA) stake by 21% in Q2 2026, selling an estimated $7.06M and leaving 504,001 shares worth $32.2M. The position accounts for 0.02% of the portfolio, ranked #462.

SG Americas Securities first reported a position in KNSA in Q2 2020 and has held it in 15 quarters since. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • SG Americas Securities held 504,001 shares of Kiniksa Pharmaceuticals worth $32.2M as of Q2 2026.
  • SG Americas Securities sold 136,178 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $7.06M.
  • Kiniksa Pharmaceuticals made up 0.02% of SG Americas Securities's portfolio in Q2 2026, its #462 holding.
  • SG Americas Securities first reported a position in Kiniksa Pharmaceuticals in Q2 2020 and has held it in 15 quarters since.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.